Literature DB >> 11818630

Pulsed arterial spin labeling: comparison of multisection baseline and functional MR imaging perfusion signal at 1.5 and 3.0 T: initial results in six subjects.

Martin N Yongbi1, Francesco Fera, Yihong Yang, Joseph A Frank, Jeff H Duyn.   

Abstract

Flow-alternating inversion-recovery magnetic resonance imaging was performed at 3.0 T to measure cerebral perfusion during rest and motor activation in six healthy adult volunteers. Results were compared with those at 1.5 T. The mean signal-to-noise ratio for both gray matter and white matter perfusion measured with and without vascular suppression at 3.0 T was significantly (P <.01) higher (n = 6) than that at 1.5 T. Brain perfusion activation maps collected during a motor task showed a substantially larger number of activated pixels (>80%) at 3.0 T, with activation in the supplementary motor area in the 3.0-T data that was not present on 1.5-T perfusion maps.

Entities:  

Mesh:

Year:  2002        PMID: 11818630     DOI: 10.1148/radiol.2222001697

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  11 in total

1.  Assessment of cerebral perfusion from bypass arteries using magnetic resonance regional perfusion imaging in patients with moyamoya disease.

Authors:  Mika Kitajima; Toshinori Hirai; Yoshinori Shigematsu; Hirofumi Fukuoka; Akira Sasao; Tomoko Okuda; Motohiro Morioka; Yutaka Kai; Yasuyuki Yamashita
Journal:  Jpn J Radiol       Date:  2010-12-30       Impact factor: 2.374

2.  Measurement of cerebral perfusion with arterial spin labeling: Part 2. Applications.

Authors:  Gregory G Brown; Camellia Clark; Thomas T Liu
Journal:  J Int Neuropsychol Soc       Date:  2007-05       Impact factor: 2.892

Review 3.  Clinical neuroimaging using arterial spin-labeled perfusion magnetic resonance imaging.

Authors:  Ronald L Wolf; John A Detre
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

4.  Dynamics of the cerebral blood flow response to brief neural activity in human visual cortex.

Authors:  Jung Hwan Kim; Amanda J Taylor; Danny Jj Wang; Xiaowei Zou; David Ress
Journal:  J Cereb Blood Flow Metab       Date:  2019-08-20       Impact factor: 6.200

Review 5.  Functional imaging for interpretation of pain pathways: current clinical application/relevance and future initiatives.

Authors:  Collin F M Clarke; Keith St Lawrence
Journal:  Curr Pain Headache Rep       Date:  2013-02

Review 6.  Current status and future perspectives of magnetic resonance high-field imaging: a summary.

Authors:  Vivek Prabhakaran; Veena A Nair; Benjamin P Austin; Christian La; Thomas A Gallagher; Yijing Wu; Donald G McLaren; Guofan Xu; Patrick Turski; Howard Rowley
Journal:  Neuroimaging Clin N Am       Date:  2012-05       Impact factor: 2.264

Review 7.  Perfusion MRI: the five most frequently asked technical questions.

Authors:  Marco Essig; Mark S Shiroishi; Thanh Binh Nguyen; Marc Saake; James M Provenzale; David Enterline; Nicoletta Anzalone; Arnd Dörfler; Alex Rovira; Max Wintermark; Meng Law
Journal:  AJR Am J Roentgenol       Date:  2013-01       Impact factor: 3.959

Review 8.  Arterial spin-labeling in routine clinical practice, part 1: technique and artifacts.

Authors:  A R Deibler; J M Pollock; R A Kraft; H Tan; J H Burdette; J A Maldjian
Journal:  AJNR Am J Neuroradiol       Date:  2008-03-27       Impact factor: 3.825

9.  Analysis of heterogeneity in T2-weighted MR images can differentiate pseudoprogression from progression in glioblastoma.

Authors:  Thomas C Booth; Timothy J Larkin; Yinyin Yuan; Mikko I Kettunen; Sarah N Dawson; Daniel Scoffings; Holly C Canuto; Sarah L Vowler; Heide Kirschenlohr; Michael P Hobson; Florian Markowetz; Sarah Jefferies; Kevin M Brindle
Journal:  PLoS One       Date:  2017-05-17       Impact factor: 3.240

10.  A Probabilistic Atlas of the Pineal Gland in the Standard Space.

Authors:  Foroogh Razavi; Samira Raminfard; Hadis Kalantar Hormozi; Minoo Sisakhti; Seyed Amir Hossein Batouli
Journal:  Front Neuroinform       Date:  2021-05-17       Impact factor: 4.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.